V-Line A Solution
V-Line A Solution
V-Line A Solution offers a nonsurgical injectable treatment that effectively targets and removes fat cells and cellulite through a carefully crafted series of processes.
Why Opt for V-Line A Solution?
- Efficiently eliminates fat cells and cellulite without causing pain
- No bruising, swelling, or redness
- Stimulates collagen, providing a lifting effect
- Prevents the formation of new fat cells
- Addresses both fat and cellulite dissolution
- Exhibits anti-inflammatory properties, reducing redness
- Free from swelling and pain
- Aids in eliminating fine lines
- No associated side effects
V-Line A Solution Overview:
V-Line A Solution is designed to efficiently remove fat cells and cellulite through a nonsurgical treatment process.
Stubborn fat cells in subcutaneous fat tissue can be challenging to reduce. This solution is specifically formulated to target "submental fat" under the chin, effectively dissolving resistant fatty deposits unresponsive to conventional diet and exercise. The treatment involves no downtime and is tailored to dissolve cheek fat and address double chin concerns.
Ingredients:
1. Soy Isoflavone Ferment
- Inhibits the generation of new fatty cells.
- Promotes lipolysis.
- Improves skin texture.
2. Carnitine
- Delivers fatty acids to mitochondria.
- Oxidatively degrades delivered fatty acids in mitochondria.
- Promotes fat degradation.
3. Visnadine
- Exhibits strong anti-phosphodiesterase activity.
- Maintains high cAMP levels in fat cells.
- Activates lipase and induces lipoclasis in fat cells.
Action of V-Line A Solution Main Ingredients:
1. Soy Isoflavone Ferment
Soy Isoflavone Ferment, similar to Estrogen, activates adenylate cyclase (lipolysis enzyme) to inhibit the generation of new fat cells. It also increases cAMP levels (transfer factor in fat cells) and induces lipolysis.
2. Carnitine and Visnadine
Carnitine delivers fatty acids degraded by lactobacillus/Soy Isoflavone Ferment to mitochondria, promoting energy metabolism. Visnadine activates lipase by increasing cAMP levels through an anti-phosphodiesterase effect.
